Chronic myeloid leukemia (CML) is characterized by the t(9;22) chromosomal translocation resulting in the formation of the BCR-ABL fusion gene. 1, 2 CML is characterized by an initial chronic phase ...
Rocket builder ABL Space closed a $170 million round of funding with a $1.3 billion valuation, making it the latest private space venture to reach unicorn status. ABL raised the funds from T. Rowe ...
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based ...
ABL Bio touts bispecific ADC gains, sets US trials for 206 and 209 Neoc Bio wins FDA clearance to begin phase 1 studies of ...
(RTTNews) - ABL Bio Inc. said that it has entered into collaboration and worldwide license agreement with Sanofi (SNYNF, SNY) to develop and commercialize ABL301, a pre-clinical stage bispecific ...
A development version of ABL Space Systems' RS1 rocket, a vehicle capable of placing up to 1,200 kilograms into low Earth orbit for $12 million. Credit: ABL Space Systems WASHINGTON — The Air Force ...
ABL tests the powerpack of the second stage of its RS1 launch vehicle at Edwards Air Force Base, California. Credit: ABL Space Systems WASHINGTON — ABL Space Systems, a three-year-old startup ...
Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up A total of 962 cases of CML on ...
Rocket builder ABL Space on Monday announced the close of a $200 million round of funding from existing investors. The financing increases the private space company's valuation to $2.4 billion. ABL ...
Kate Starbird and Jamila Wideman sat in a conference room after finishing their senior seasons at Stanford in April 1997 with something that hadn't been previously available to women's college ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results